The American Society of Hematology (ASH) has created a resource webpage in the midst of the global pandemic to provide public health professionals and the general public with haematology-specific up-to-date COVID-19 information in a series of Frequently Asked Questions (FAQs), as well as insights into COVID-19 treatment and several links to relevant resources, including research updates and health e-stats. Specifically, in the non-malignant category, ASH publishes FAQs on sickle cell disease (SCD, link) and thalassaemia (link) to help guide providers who are less familiar with these diseases to care and treat SCD and thalassaemia patients infected with COVID-19. All of the COVID-19 content is free to access. For more information, see here.